Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

Update Il y a 4 ans
Reference: NCT00922896

Woman and Man

Extract

The purpose of this study is to determine the response rate of gemcitabine, cisplatin and erlotinib in metastatic pancreatic cancer.


Inclusion criteria

  • Metastatic Pancreatic Cancer

Links